Post-traumatic stress disorder (PTSD) is a mental health condition that can develop after a person experiences or witnesses a deeply distressing event. Not everyone who goes through trauma will develop PTSD, but for some people the effects can be long-lasting and significantly affect daily life. According to Healthdirect, about
12 in every 100 Australians will experience PTSD at some time in their lives.
Symptoms can appear soon after a traumatic event or emerge months later, and may include intrusive memories, heightened anxiety, changes in mood, and difficulty with everyday activities. They can intensify during periods of stress or when a person encounters reminders of the trauma.
Current treatments help many people, but they don't work equally well for everyone. This trial is evaluating a once-daily investigational tablet that works by
supporting the function of astrocytes, cells in the brain and nervous system that play a role in how we process and respond to stress, to assess whether it can help reduce PTSD symptoms in people living with the condition.
treatment design
Eligible participants will be randomly assigned to receive either the investigational tablet or a placebo, taken once daily throughout the 13-week PTSD trial. Participants will attend up to 5 clinic visits at our Morayfield clinic.
Throughout the study, our experienced clinical team will monitor your health and wellbeing closely. You are free to withdraw at any time. All procedures will be explained clearly before you consent to take part, and you can ask questions at any time.
